Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omidria with Dextenza or Dexycu vs Prednisolone in Cataract Surgery
NCT04316936Phase 4Completed
- Sponsor
- Silverstein Eye Centers
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Polymer-based Nanoparticles, Implantable Devices, Implantable Hydrogels
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex, IBI-10090 in post-operative inflammation, postoperative pain, sponsored by Silverstein Eye Centers. Started Dec 2019; status: completed.
02
Drugs
ozurdexIBI-10090
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT04316936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04316936.